Management of giant coronary artery aneurysms due to Kawasaki syndrome

ACC Current Journal Review

Volumn 5, Issue 4, 1996, Pages 74-76

  Takahashi, Masato ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; UROKINASE; WARFARIN;

CORONARY ARTERY ANEURYSM; ECHOCARDIOGRAPHY; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MUCOCUTANEOUS LYMPH NODE SYNDROME; SHORT SURVEY; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0030198155     PISSN: 10621458     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1062-1458(96)00066-9     Document Type: Short Survey

References (14)

1. 1. Kawasaki T, Kosaki F, Osawa S. et al. A new infantile acute febrile mucocutaneous lymph node syndrome (MCLS) prevailing in Japan. Pediatrics 1984;54:271-6.
2. 2. Melish M, Hicks R, Larsen E. Kawasaki syndrome in the United States. Am J Dis Child 1976:130:599-607.
3. 3. Dajani AS, Taubert KA, Takahashi M, et al. Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 1994;89:916-22.
4. 4. Takahashi M, Mason W, Lewis AB. Regression of coronary aneurysms in patients with Kawasaki syndrome. Circulation 1987;75:387-94.
5. 5. Kato H (ed): Kawasaki Disease. Proceedings of the 5th International Kawasaki Disease Symposium. Amsterdam: Elsevier, 1995.
6. 6. Nakano H, Ueda K, Saito A, Nojima K. Repeated quantitative angiograms in coronary arterial aneurysm in Kawasaki disease. Am J Cardiol 1985:56:846-51.
7. 7. Tatara K, Kusakawa S. Long-term prognosis of giant coronary aneurysm in Kawasaki disease: An angiographic study. J Pediatr 1987;111:705-10.
8. 8. Newburger JW, Takahashi M, Beiser AS, et al. A single intravenous infusion of gammaglobulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 1991;324:1633-9.
9. 9. Rowley AH, Duffy E, Shulman ST. Prevention of giant coronary artery aneurysms in Kawasaki disease by intravenous gammaglobulin. J Pediatr 1988;113:290-4.
10. 10. Suzuki A, Kamiya T, Ono Y. Kuroe K. Follow-up study of coronary arterial lesions caused by Kawasaki disease. In: Takahashi M, Taubert K, eds. Proceedings of the Fourth International Symposium on Kawasaki Disease. Dallas: American Heart Association 1993:317-23.
11. 11. Kato H, Ichmose E, Kawasaki T. Myocardial infarction in Kawasaki disease: Clinical analysis of 195 cases. J Pediatr 1986;108:923-7.
12. 12. Hijazi ZM, Udelson JE, Snapper H, Rhodes J et al. Physiologic significance of chronic coronary aneurysms in patients with Kawasaki disease. J Am Coll Cardiol 1994;24:1633-8.
13. 13. Paridon SM, Galioto FM, Vincent JA, Tomassoni TL, et al. Exercise capacity and incidence of myocardial perfusion defects after Kawasaki disease in children and adolescents. J Am Coll Cardiol 1995;25:1420-4.
14. 14. Kitamura S, Kameda Y, Seki T, et al. Long-term outcome of myocardial revascularization in patients with Kawasaki coronary artery disease. A multicenter cooperative study. J Thorac Cardiovasc Surg 1994;107:663-73.